Aehr Test Systems (NASDAQ:AEHR – Get Free Report) Director Laura Oliphant sold 5,000 shares of the stock in a transaction on Friday, July 25th. The shares were sold at an average price of $21.50, for a total value of $107,500.00. Following the completion of the sale, the director owned 7,665 shares in the company, valued at approximately $164,797.50. This trade represents a 39.48% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Aehr Test Systems Price Performance
Shares of NASDAQ AEHR opened at $21.74 on Friday. The stock’s fifty day moving average price is $12.86 and its two-hundred day moving average price is $10.87. Aehr Test Systems has a one year low of $6.27 and a one year high of $23.00. The firm has a market cap of $647.20 million, a price-to-earnings ratio of -167.22 and a beta of 2.29.
Aehr Test Systems (NASDAQ:AEHR – Get Free Report) last issued its quarterly earnings data on Tuesday, July 8th. The semiconductor company reported ($0.01) EPS for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.01. Aehr Test Systems had a negative return on equity of 0.15% and a negative net margin of 6.63%. The firm had revenue of $14,100 billion for the quarter, compared to analyst estimates of $14.83 million. On average, equities analysts anticipate that Aehr Test Systems will post 0.1 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Get Our Latest Report on Aehr Test Systems
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently added to or reduced their stakes in AEHR. Raymond James Financial Inc. acquired a new position in Aehr Test Systems in the 4th quarter valued at $272,000. HighTower Advisors LLC grew its holdings in Aehr Test Systems by 18.1% in the 4th quarter. HighTower Advisors LLC now owns 13,256 shares of the semiconductor company’s stock valued at $220,000 after buying an additional 2,032 shares in the last quarter. LPL Financial LLC acquired a new stake in shares of Aehr Test Systems during the 4th quarter worth $874,000. Vanguard Group Inc. grew its holdings in shares of Aehr Test Systems by 2.1% during the 4th quarter. Vanguard Group Inc. now owns 2,183,641 shares of the semiconductor company’s stock worth $36,314,000 after purchasing an additional 44,881 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its holdings in shares of Aehr Test Systems by 15.4% during the 4th quarter. JPMorgan Chase & Co. now owns 15,591 shares of the semiconductor company’s stock worth $259,000 after purchasing an additional 2,076 shares in the last quarter. 69.69% of the stock is owned by institutional investors and hedge funds.
About Aehr Test Systems
Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.
Recommended Stories
- Five stocks we like better than Aehr Test Systems
- Financial Services Stocks Investing
- 3 Stocks Flying Under the S&P 500 Radar
- Are Penny Stocks a Good Fit for Your Portfolio?
- Qualcomm’s Next Gear: A Growth Story Wall Street Might Be Missing
- How to Calculate Stock Profit
- 3 Cloud Build-Out Stocks Behind the AI Infrastructure Boom
Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.